Latest intangible assets for LEGN: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Legend Biotech (LEGN) currently reports a intangible assets of $0 as of March 2026. That compares with $180M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Legend Biotech's intangible assets history and peer comparisons.
Legend Biotech's intangible assets decreased from $180M to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Legend Biotech reported $0 in intangible assets as of March 2026. That compares with $180M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Legend Biotech, and consider following LEGN for alerts when major investors trade the stock.
Legend Biotech is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LEGN with unrelated industries.